We used a bioinformatic approach [cBioPortal; [34,35]] to determine if BRN2/POU3F2 gene expression correlates with breast cancer patient survival and compare BRN2 gene expression between hormone receptor-positive and basal-like subtypes of breast cancer. This evidence concerns the gene POU3F2 and breast carcinoma.